ReWalk Robotics Announces Exercise of Warrants Resulting in Cash Proceeds of $10.8 Million
06/05/19
FDA Issues Clearance for the ReStore™ Exo-Suit, the First Soft Robotic System for Stroke Therapy
06/04/19
ReWalk Robotics Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device
05/29/19
ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again
04/25/19
ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market
04/05/19
Displaying 193 - 204 of 348